Literature DB >> 35883009

China approves first homegrown COVID antiviral.

Yvaine Ye.   

Abstract

Entities:  

Keywords:  Drug discovery; SARS-CoV-2

Year:  2022        PMID: 35883009     DOI: 10.1038/d41586-022-02050-x

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  1 in total

1.  Azvudine (FNC): a promising clinical candidate for COVID-19 treatment.

Authors:  Bin Yu; Junbiao Chang
Journal:  Signal Transduct Target Ther       Date:  2020-10-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.